ATHEROSCLEROSE: PATHOGENIE ET FACTEURS DE RISQUEFUSTER V.1981; COEUR; ISSN 0010-0226; FRA; DA. 1981; VOL. 12; NO 1; PP. 65-92; 22 P.; ABS. ENG; BIBL. 340 REF.Article

Mechanisms of arterial thrombosis : Foundation for therapyFUSTER, V.The American heart journal. 1998, Vol 135, Num 6, pp S361-S366, issn 0002-8703, 3Conference Paper

PLATELETS AND PLATELET-INHIBITOR DRUGS IN AORTOCORONARY VEIN BYPASS OPERATIONSCHESEBRO JH; FUSTER V.1983; INTERNATIONAL JOURNAL OF CARDIOLOGY; ISSN 0167-5273; NLD; DA. 1983; VOL. 2; NO 5-6; PP. 511-516; BIBL. 15 REF.Article

SURGICAL REPAIR OF EBSTEIN'S ANOMALYDANIELSON GK; FUSTER V.1982; ANN. SURG.; ISSN 0003-4932; USA; DA. 1982; VOL. 196; NO 4; PP. 499-504; BIBL. 13 REF.Article

THE VON WILLEBRAND PIG AS A MODEL FOR ATHEROSCLEROSIS RESEARCHFUSTER V; BOWIE EJW.1978; THROMBOSIS AND HAEMOSTASIS; DEU; DA. 1978; VOL. 39; NO 2; PP. 322-327; ABS. FRE/GER; BIBL. 2 P.Article

ACTIONS AND CLINICAL STATUS OF PLATELET-SUPPRESSIVE AGENTS.DIDISHEIM P; FUSTER V.1978; SEMINARS HEMATOL.; U.S.A.; DA. 1978; VOL. 15; NO 1; PP. 55-72; BIBL. 5 P.Article

ANTITHROMBOTIC THERAPY: ROLE OF PLATELET-INHIBITOR DRUGS. II: PHARMACOLOGIC EFFECTS OF PLATELET-INHIBITOR DRUGSFUSTER V; CHESEBRO JH.1981; MAYO CLIN. PROC.; ISSN 0025-6196; USA; DA. 1981; VOL. 56; NO 3-4; PP. 185-195; BIBL. 171 REF.Article

VON WILLEBRAND'S DISEASE IN PIGS AND ATHEROSCLEROSISFUSTER V; BOWIE EJW.1979; RIC. CLIN. LAB.; ITA; DA. 1979; VOL. 9; NO 4; PP. 319-326; BIBL. 59 REF.Article

Relationship by isonymy and migration pattern in Northwest SpainFUSTER, V.Human biology. 1986, Vol 58, Num 3, pp 391-406, issn 0018-7143Article

Lewis. A Conner memorial lecture : mechanisms leading to myocardial infarction : insights from studies of vascular biologyFUSTER, V.Circulation (New York, N.Y.). 1994, Vol 90, Num 4, pp 2126-2146, issn 0009-7322Article

CORONARY COLLATERAL VESSELS AND MYOCARDIAL PROTECTIONAMBROSE JA; FUSTER V.1983; INTERNATIONAL JOURNAL OF CARDIOLOGY; ISSN 0167-5273; NLD; DA. 1983; VOL. 3; NO 4; PP. 417-420; BIBL. 12 REF.Article

DRUG TRIALS IN PREVENTION OF OCCLUSION OF AORTA-CORONARY ARTERY VEINGRAFTSCHESEBRO JH; FUSTER V.1982; J. THORAC. CARDIOVASC. SURG.; ISSN 0022-5223; USA; DA. 1982; VOL. 83; NO 1; PP. 90-93; BIBL. 28 REF.Article

PLATELET FUNCTION INHIBITORS: THEIR CLINICAL USE.FUSTER V; DIDISHEIM P.1978; ADV. INTERN. MED.; U.S.A.; DA. 1978; VOL. 23; PP. 251-264; BIBL. 3 P. 1/2Article

DAILY AND SEASONAL VARIATION IN SUDDEN CARDIAC DEATH, ROCHESTER, MINNESOTA, 1950-1975BEARD CM; FUSTER V; ELVEBACK LR et al.1982; MAYO CLIN. PROC.; ISSN 0025-6196; USA; DA. 1982; VOL. 57; NO 11; PP. 704-706; BIBL. 5 REF.Article

DIPYRIDAMOLE LEVELS IN PLASMA OF MAN AND OTHER SPECIESTYCE GM; FUSTER V; OWEN CA JR et al.1979; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; USA; DA. 1979; VOL. 26; NO 3; PP. 495-508; BIBL. 2 P.Article

PLATELET INHIBITION IN THE MANAGEMENT OF THROMBOSIS = INHIBITEURS DES FONCTIONS PLAQUETTAIRES DANS LE TRAITEMENT DE LA THROMBOSEDIDISHEIM P; KAZMIER FJ; FUSTER V et al.1974; THROMBOSIS DIATHESIS HAEMORRHAG.; ALLEM.; DA. 1974; VOL. 32; NO 1; PP. 21-34; ABS. FR. ALLEM.; BIBL. 3P. 1/2; (SYMP. THROMB. AM. SOC. HEMATOL. MEET.; CHICAGO; 1973)Conference Paper

PLATELET KINETIC AND THE EFFECT OF ASPIRIN IN CHRONICALLY INDUCED INTRAVASCULAR COAGULATION IN DOGS = CINETIQUE PLAQUETTAIRE ET L'EFFET DE L'ASPIRINE DANS LA COAGULATION INTRAVASCULAIRE INDUITE CHRONIQUEMENT CHEZ LE CHIENFUSTER V; OWEN CA JR; PINTADO T et al.1974; THROMBOSIS DIATHESIS HAEMORRHAG., SUPPL.; ALLEM.; DA. 1974; NO 60; PP. 371-376; BIBL. 4REF.; (PLATELETS THROMB. INHIBITORS. PROC. SEMIN.; HONOLULU, HAWAII; 1973)Conference Paper

THROMBOCYTES IN ATHEROSCLEROSIS-RESISTANT AND ATHEROSCLEROSIS-SUSCEPTIBLE BRUDS OF PIGEON: A COMPARATIVE ULTRASTRUCTURAL STUDY.LEWIS JC; FUSTER V; KOTTKE BA et al.1976; EXPER. MOLEC. PATHOL.; U.S.A.; DA. 1976; VOL. 25; NO 3; PP. 332-343; BIBL. 21 REF.Article

The generalist/cardiovascular specialist : A proposal for a new training trackFUSTER, V; NASH, I. S.Annals of internal medicine. 1997, Vol 127, Num 8, pp 630-634, issn 0003-4819, 1Article

Fifty years of experience with antithrombotic therapy in cardiac disease : A 1996 approach based on pathogenesis and risk : Part B : Alumni theme issueFREUDENBERGER, R. S; FUSTER, V.The Mount Sinai journal of medicine. 1996, Vol 63, Num 5-6, pp 342-358, issn 0027-2507Article

Guide to anticoagulant therapy. I: HeparinHIRSH, J; FUSTER, V.Circulation (New York, N.Y.). 1994, Vol 89, Num 3, pp 1449-1468, issn 0009-7322Article

STRONG FAMILY HISTORY AND CIGARETTE SMOKING AS RISK FACTORS OF CORONARY ARTERY DISEASE IN YOUNG ADULTSCHESEBRO JH; FUSTER V; ELVEBACK LR et al.1982; BR. HEART J.; ISSN 0007-0769; GBR; DA. 1982; VOL. 47; NO 1; PP. 78-83; BIBL. 26 REF.Article

A SENSITIVE NEW METHOD OF "EX VIVO" PLATELET DEPOSITIONBADIMON L; FUSTER V; DEWANJEE MK et al.1982; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1982; VOL. 28; NO 2; PP. 237-250; BIBL. 14 REF.Article

LONG-TERM EVALUATION (12 TO 22 YEARS) OF OPEN HEART SURGERY FOR TETRALOGY OF FALLOTFUSTER V; MCGOON DC; KENNEDY MA et al.1980; AM. J. CARDIOL.; ISSN 0002-9149; USA; DA. 1980; VOL. 46; NO 4; PP. 635-642; BIBL. 35 REF.Article

Determinants of protogenetic interval in a West Mediterranean rural population : La Alpujarra (Southeast Spain) = Déterminants de l'intervalle protogénétique dans une population rurale de la Méditerranée occidentale : La Alpujarra (Espagne du Sud-Est)LUNA, F; FUSTER, V.Anthropologischer Anzeiger. 1999, Vol 57, Num 4, pp 319-324, issn 0003-5548Article